Initial Medication in Patients of Newly Diagnosed Parkinson’s Disease in Taiwan

Open Access

Peer-reviewed

Research Article

Yi-Jen Guo,

Affiliations Section of Neurology, Taichung Veterans General Hospital, Taichung, Taiwan, Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan
⨯
Yi-Chu Liao,

Affiliations Section of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan, Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan
⨯
Ching-Heng Lin ,

Contributed equally to this work with: Ching-Heng Lin, Ming-Hong Chang

Affiliation Department of Medical education and Research, Taichung Veterans General Hospital, Taichung, Taiwan
⨯
Ming-Hong Chang

Contributed equally to this work with: Ching-Heng Lin, Ming-Hong Chang

* E-mail: cmh50@ms10.hinet.net

Affiliations Section of Neurology, Taichung Veterans General Hospital, Taichung, Taiwan, Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan
⨯

Reader Comments (0)

Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Physicians
Is the Subject Area "Physicians" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.
Cardiology
Is the Subject Area "Cardiology" applicable to this article?

Thanks for your feedback.
Gastroenterology and hepatology
Is the Subject Area "Gastroenterology and hepatology" applicable to this article?

Thanks for your feedback.
Neurology
Is the Subject Area "Neurology" applicable to this article?

Thanks for your feedback.
Taiwan
Is the Subject Area "Taiwan" applicable to this article?

Thanks for your feedback.